Scilex Holding (SCLXW) Amortizatization of Intangibles (2022)
Scilex Holding (SCLXW) recorded quarterly Amortizatization of Intangibles of $1155.0 in Q3 2022, down 86.05% quarter-over-quarter from $8280.0 in Q2 2022.
Scilex Holding (SCLXW) Amortizatization of Intangibles (2022) Analysis & Trends
Scilex Holding's Amortizatization of Intangibles history runs 1 years deep, the most recent figure standing at $1155.0 for Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | - |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 1.70 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 931.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 596.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Scilex Holding | - | - | 4.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1,155.00 |
| Sep 30, 2022 | 1,155.00 |
| Jun 30, 2022 | 8,280.00 |
| Jun 30, 2022 | 8,280.00 |
| Mar 31, 2022 | 7,466.00 |
| Mar 31, 2022 | 7,466.00 |